chaetocin   Click here for help

GtoPdb Ligand ID: 8388

Comment: Chaetocin is a fungal mycotoxin specifically inhibiting the histone methyltransferase (HMT), suppressor of variegation 3-9 homolog 1 (SUV39H1) [2-3]. SUV39H1 is the main enzyme responsible for the trimethylation of lysine 9 in histone H3.
We show the chemical structure here without any stereochemical specification. PubChem records various stereoisomers of this naturally ocurring metabolite.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 12
Hydrogen bond donors 4
Rotatable bonds 3
Topological polar surface area 246.96
Molecular weight 696.1
XLogP -1.21
No. Lipinski's rules broken 1
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES OCC12SSC3(N(C1=O)C1Nc4c(C1(C3)C13CC56N(C3Nc3c1cccc3)C(=O)C(SS5)(N(C6=O)C)CO)cccc4)C(=O)N2C
Isomeric SMILES OCC12SSC3(N(C1=O)C1Nc4c(C1(C3)C13CC56N(C3Nc3c1cccc3)C(=O)C(SS5)(N(C6=O)C)CO)cccc4)C(=O)N2C
InChI InChI=1S/C30H28N6O6S4/c1-33-21(39)27-11-25(15-7-3-5-9-17(15)31-19(25)35(27)23(41)29(33,13-37)45-43-27)26-12-28-22(40)34(2)30(14-38,46-44-28)24(42)36(28)20(26)32-18-10-6-4-8-16(18)26/h3-10,19-20,31-32,37-38H,11-14H2,1-2H3
InChI Key PZPPOCZWRGNKIR-UHFFFAOYSA-N
References
1. Chaib H, Nebbioso A, Prebet T, Castellano R, Garbit S, Restouin A, Vey N, Altucci L, Collette Y. (2012)
Anti-leukemia activity of chaetocin via death receptor-dependent apoptosis and dual modulation of the histone methyl-transferase SUV39H1.
Leukemia, 26 (4): 662-74. [PMID:21979880]
2. Cherblanc FL, Chapman KL, Brown R, Fuchter MJ. (2013)
Chaetocin is a nonspecific inhibitor of histone lysine methyltransferases.
Nat Chem Biol, 9 (3): 136-7. [PMID:23416387]
3. Greiner D, Bonaldi T, Eskeland R, Roemer E, Imhof A. (2005)
Identification of a specific inhibitor of the histone methyltransferase SU(VAR)3-9.
Nat Chem Biol, 1 (3): 143-5. [PMID:16408017]
4. Isham CR, Tibodeau JD, Jin W, Xu R, Timm MM, Bible KC. (2007)
Chaetocin: a promising new antimyeloma agent with in vitro and in vivo activity mediated via imposition of oxidative stress.
Blood, 109 (6): 2579-88. [PMID:17090648]